Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by crow27 on Feb 18, 2021 10:03am

What's Next?

Now Dan can announce another partnership
Comment by Actuarial on Feb 18, 2021 10:09am
I don't think so. If another partnership in near term, there is no need to have a bought deal. Most likely, ATE/AH deal might announce any time. Hopefully, ATE don't have to pay AH cash in order to fully own the platform.
Comment by Layth1990 on Feb 18, 2021 10:15am
i don't this so because yesterday's News clearly say to fully fund phase 3. that means  it will be used for phase 3 and not paying for the IP
Comment by Yellowknifer69 on Feb 18, 2021 10:10am
Roger that Crow!   I am totally going to back you on that.  Reading through some of the other commentary here, I am of the opinion that this bought financing is much different than last June. Sure, same players, but the Nuance deal gives Antibe way more leverage going into this round of Fund Raising.  Smart move.  They need money for P3 but they had options.    ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities